• 1
    Nativ O, Sabo E, Bejar J, Halachmi S, Moskovitz B, Miselevich I. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma. Br J Urol 1996; 78: 338
  • 2
    Ruiz-Cerda JL, Hernandez M, Gomis F et al. Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma. J Urol 1996; 155: 45965
  • 3
    Ruiz JL, Hernandez M, Martinez J, Vera J, Jimenez-Cruz JF. Value of morphometry as an independent prognostic factor in renal cell carcinoma. Eur Urol 1995; 27: 547
  • 4
    Carducci MA, Piantadosi S, Pound CR et al. Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma. Urology 1999; 53: 449DOI: 10.1016/s0090-4295(98)00440-3
  • 5
    Tosi P, Luzi P, Baak JP et al. Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma. Cancer 1986; 58: 25128
  • 6
    Delahunt B. Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol 1998; 15: 6876
  • 7
    Eskelinen M, Lipponen P, Aitto-Oja L, Hall O, Syrjanen K. The value of histoquantitative measurements in prognostic assessment of renal adenocarcioma. Int J Cancer 1993; 55: 54754
  • 8
    Mohler JL, Partin AW, Lohr WD, Coffey DS. Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. I. Testing of digitization system. J Urol 1988; 139: 10804
  • 9
    Mohler JL, Partin AW, Epstein JI, Lohr WD, Coffey DS. Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections. J Urol 1988; 139: 10859
  • 10
    Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 65563
  • 11
    Harmanec P, Hutter RVP, Sobin LH, Wagner G, Wittekind C. TNM Atlas. 4th edn. Berlin: Springer, 1997: 296302
  • 12
    De Manzoni G, Verlato G, Tomezzoli A et al. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn J Clin Oncol 1998; 28: 5347
  • 13
    Delahunt B, Bethwaite PB, Thornton A, Ribas JL. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Cancer 1995; 75: 27149
  • 14
    Tomera KM, Farrow GM, Leiber MM. Sarcomatoid renal cell carcinoma. A study of 42 cases. J Urol 1983; 130: 6579
  • 15
    Gutierrez JL, Val-Bernal JF, Garijo MF, Buelta L, Portillo JA. Nuclear morphometry in prognosis of renal adenocarcinoma. Urology 1992; 39: 1304
  • 16
    Francois C, Decaestecker C, Petein M et al. Classification strategies for the grading of renal cell carcinomas, based on nuclear morphometry and densitometry. J Pathol 1997; 183: 14150DOI: 10.1002/(sici)1096-9896(199710)183:2<141::aid-path916>;2-0
  • 17
    Paraskevakou E, Kavantzas N, Pavlopoulos PM, Delibasis A, Yova D, Davaris P. Computerized nuclear morphometry of renal cell carcinomas. General Diagn Pathol 1996; 142: 1014
  • 18
    Diamond DA, Berry SJ, Umbricht C, Jewett HJ, Coffey DS. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer. Prostate 1982; 3: 3217
  • 19
    Monge JM, Val-Bernal JF, Buelta L, Garcia-Castrillo L, Asensio L. Selective nuclear morphometry as a prognostic factor of survival in renal cell carcinoma. Histol Histopathol 1999; 14: 11923
  • 20
    Barth PJ, Siebel A, Gerharz E, Kohler HH. Nuclear morphometry of renal cell carcinomas. General Diagn Pathol 1995; 141: 2933
  • 21
    Delahunt B, Becker RL, Bethwaite PB, Ribas JL. Computerized nuclear morphometry and survival in renal cell carcinoma: comparison with other prognostic indicators. Pathology 1994; 26: 3538
  • 22
    Pound CR, Partin AW, Epstein JI, Simons JW, Marshall FF. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology 1993; 42: 2438
  • 23
    Thrasher JB, Paulson DF. Prognostic factors in renal cancer. Urol Clin North Am 1993; 20: 24762
  • 24
    Fujikawa K, Sasaki M, Aoyama T, Itoh T. Role of volume-weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma. J Urol 1997; 157: 123741


  1. Authors

E. Özer, MD, Associate Professor.

K. Yörükogˇlu, MD, Professor.

Ö. Sagol, MD, Associate Professor.

U. Mungan, MD, Associate Professor.

D. Demirel, MD, Associate Professor.

E. Tüzel, MD, Urologist.

Z. Kirkali, MD, Professor.


labelling index


mean nuclear area


mean nuclear perimeter


mean nuclear major diameter


mean nuclear minor diameter


mean nuclear form factor.